Comparative multicentre double-blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis
- 1 January 1997
- journal article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 8 (2) , 93-97
- https://doi.org/10.3109/09546639709160278
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosisJournal of the American Academy of Dermatology, 1995
- Determination of terbinafine and its desmethyl metabolite in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Oral therapeutic agents in fungal nail diseaseJournal of the American Academy of Dermatology, 1994
- Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 daysClinical and Experimental Dermatology, 1994
- Terbinafine in Onychomycosis—A Mini StudyInternational Journal of Dermatology, 1993
- Treatment of onychomycosis with terbinafineBritish Journal of Dermatology, 1992
- A randomized treatment duration-finding study of terbinafine in onychomycosisBritish Journal of Dermatology, 1992
- Short-duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trialBritish Journal of Dermatology, 1992
- Terbinafine: Mode of action and properties of the squalene epoxidase inhibitionBritish Journal of Dermatology, 1992
- The mechanism of action of terbinafineClinical and Experimental Dermatology, 1989